Cell Therapy Market Report 2026: Strategic Insights and Revenue Outlook

Uncover key drivers, emerging technologies, and competitive movements shaping the cell therapy market from 2026–2035 with trusted insights from The Business Research Company

What level of growth is expected in the Cell Therapy Market between 2026 and 2030?

The cell therapy market size has witnessed substantial growth in recent years. It is projected to expand from $16.87 billion in 2025 to $19.31 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 14.5%. The historical growth of this market can be ascribed to elements such as the elevated cost of autologous therapies, restricted donor availability, a deficiency in standardized manufacturing, the success of early-stage clinical trials, and the rising prevalence of chronic diseases.

The cell therapy market is poised for substantial growth over the next few years. It is projected to expand to $32.48 billion by 2030, achieving a compound annual growth rate (CAGR) of 13.9%. This anticipated expansion during the forecast period stems from various factors, including breakthroughs in gene editing, increased automation in cell manufacturing processes, rising investments in cell therapy startups, an escalating demand for regenerative medicine, and wider applications across oncology and cvd. Significant trends during this period are expected to involve the progression of personalized cell therapy, advancements in allogeneic therapies, improvements in cell storage and transportation, innovations in regulatory and compliance frameworks, and the introduction of new clinical applications.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3393&type=smp

Which Drivers Are Expected To Impact The Cell Therapy Market During The Forecast Period?

The increasing occurrence of chronic illnesses supported the expansion of the cell therapy market. The US Centers for Disease Control and Prevention (CDC) defines chronic disease as a condition that lasts for one year or more, requires medical attention, limits daily activities, or both, and includes heart disease, cancer, diabetes, and Parkinson’s disease. Stem cells demonstrate potential benefits for patients suffering from spinal cord injuries, type 1 diabetes, Parkinson’s disease (PD), heart disease, cancer, and osteoarthritis. For instance, in July 2024, the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, released significant updates regarding public health initiatives. Annually, over 944,800 Americans die from heart disease or stroke, accounting for more than one-third of all deaths. In the U.S., 1.7 million individuals are diagnosed with cancer each year, with over 600,000 fatalities, making it the second leading cause of death. Additionally, more than 38 million Americans have diabetes, while another 98 million adults are prediabetic, which elevates their risk for type 2 diabetes. Diabetes can lead to severe complications such as heart disease, kidney failure, and blindness. Obesity impacts 20% of children and 42% of adults, heightening the risk of chronic diseases like type 2 diabetes, heart disease, and certain cancers. The expanding prevalence of chronic diseases has boosted the demand for cell therapies and contributed to the growth of the cell therapy market.

How Is The Cell Therapy Market Divided Into Segments?

The cell therapy market covered in this report is segmented –

1) By Technique: Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy

2) By Therapy Type: Allogeneic Therapies, Autologous Therapies

3) By Application: Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing, Other Applications

Subsegments:

1) By Stem Cell Therapy: Hematopoietic Stem Cell Transplantation, Mesenchymal Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy

2) By Cell Vaccine: Dendritic Cell Vaccine, Tumor-Infiltrating Lymphocyte (TIL) Vaccine, Antigen-Specific Cell Vaccine

3) By Adoptive Cell Transfer (ACT): CAR T-Cell Therapy, T-Cell Receptor (TCR) Therapy, Natural Killer (NK) Cell Therapy

4) By Fibroblast Cell Therapy: Dermal Fibroblast Therapy, Adipose-Derived Stem Cell Therapy

5) By Chondrocyte Cell Therapy: Autologous Chondrocyte Implantation (ACI), Chondral Graft Therapy

What Trends Are Projected To Support The Growth Of The Cell Therapy Market?

Leading companies in the cell therapy market are developing advanced, multi-targeted therapies, supported by strong early-stage clinical data, to enhance treatment effectiveness and address unmet needs in complex cancers. For example, in June 2025, Johnson & Johnson, a US-based pharmaceutical entity, reported promising initial outcomes from its Phase 1b study of JNJ-4496, a dual-targeting CAR T-cell therapy designed to bind both CD19 and CD20 in individuals with relapsed or refractory large B-cell lymphoma. Early data presented at the 2025 EHA Congress revealed substantial response rates, achieving 75–80% complete responses at the recommended Phase 2 dose, with no occurrences of Grade 3–4 cytokine release syndrome. The therapy demonstrated encouraging safety profiles, manageable neurotoxicity, and robust activity even in heavily pretreated patients. These findings emphasize the potential of next-generation dual-targeting CAR T methods and strengthen Johnson & Johnson’s commitment to progressing innovative treatments for B-cell malignancies.

Which Key Players Are Driving Competition In The Cell Therapy Market?

Major companies operating in the cell therapy market are Stempeutics Research Pvt. Ltd., Osiris Therapeutics Inc., Vericel Corporation, AlloSource, Anterogen Co. Ltd., MediPost Co. Ltd., Pharmicell Co. Ltd., Corestem Inc., Stemedica Cell Technologies Inc., Adaptimmune Therapeutics plc, Mesoblast Ltd., Cell Medica Ltd., Cellerant Therapeutics Inc., Kolon TissueGene Inc., Athersys Inc., Forticell Bioscience Inc., Bone Therapeutics, Holostem Terapie Avanzate S.r.l, Fibrocell Science Inc., AlloCure Inc., TiGenix NV, Cells for Cells, Cellular Biomedicine Group Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Which Region Is Projected To Lead The Cell Therapy Market During The Forecast Period?

North America was the largest region in the cell therapy market in 2025. The regions covered in the cell therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Cell Therapy Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=3393&type=smp

Browse Through More Reports Similar to the Global Cell Therapy Market 2026, By The Business Research Company

Cells Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Cell Therapy Technologies Market Report 2026

https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report

Autologous Cell Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/autologous-cell-therapy-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795